what insurance covers glp 1 drugs for weight loss Employers Take a Variety of Approaches to GLP-1 Coverage Why payers are hesitant to

Speliotes, E

2021;3:fcab202 Cazalis F, Feydy A, Valabrgue R, Plgrini-Issac M, Pierot L, Azouvi P

Every person has a different starting point , different health considerations , and different goals

There are also risk / benefit considerations in the selection of the health care provider{s) who prescribe and may also provide the medication

Most of them were not on nephroprotective drugs such as SGLT-2 inhibitors (75%) and mineralocorticoid receptor antagonists (92%), while 81% of patients were on ACE-I or ARBs [49]

Compounding may be appropriate when: A required dose, concentration, or formulation is not commercially available An FDA-approved drug is in a temporary shortage A patient has a documented allergy or intolerance to an inactive ingredient Compounding is intended to address medical necessity , not convenience, mass substitution, or price alone